His 태그 항체 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 표지 유형별, 용도별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global His-Tag Antibody Market size was valued at USD 285.0 Million in 2024 and is poised to grow from USD 309.8 Million in 2025 to USD 603.83 Million by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).

The global His-tag antibody market focuses on reagents that detect polyhistidine sequences in recombinant proteins, essential for affinity purification and detection. His-tagged constructs are prevalent in biopharmaceuticals, academia, and diagnostics, enhancing downstream processing and reducing costs. With advancements in antibody engineering and high-throughput screening, the market has expanded to include customizable clones capable of withstanding harsh conditions, which is vital for large-scale production. The growing demand for biologics, particularly monoclonal antibodies and gene therapy vectors that utilize polyhistidine tags, drives the need for high-affinity anti-His reagents suitable for GMP compliance. This trend optimizes production efficiency, as seen in the manufacturing of viral proteins. Consequently, suppliers are exploring innovative formats to cater to specialized applications, creating opportunities for niche market players.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global His-Tag Antibody market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global His-Tag Antibody Market Segments Analysis

Global his-tag antibody market is segmented by product type, label type, application, end user, distribution channel and region. Based on product type, the market is segmented into Monoclonal Antibodies and Polyclonal Antibodies. Based on label type, the market is segmented into Unconjugated, HRP Conjugated, Fluorescent Conjugated and Others. Based on application, the market is segmented into Western Blotting, ELISA, Immunoprecipitation and Others. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Academic Institutes and CROs. Based on distribution channel, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global His-Tag Antibody Market

A key market driver for the global His-Tag antibody market is the increasing demand for recombinant proteins in research and therapeutic applications. As the biotechnology and pharmaceutical industries continue to expand, there is a heightened need for efficient purification methods to isolate and characterize proteins. His-Tag antibodies play a critical role in facilitating these processes, enabling researchers to streamline protein expression and purification workflows. Additionally, the growing focus on monoclonal antibodies and their applications in personalized medicine further propels the demand for His-Tag antibodies, as they are essential tools for understanding protein interactions and developing targeted therapies.

Restraints in the Global His-Tag Antibody Market

One key market restraint for the global His-Tag antibody market is the high cost associated with the development and production of these specialized antibodies. The intricate process of designing, engineering, and validating His-Tag antibodies requires significant investment in research and development, which can deter smaller biotechnology firms and academic institutions from entering the market. Additionally, the reliance on advanced technologies and skilled personnel further escalates costs, creating barriers to entry. This financial burden can limit the accessibility of His-Tag antibodies, potentially stalling innovation and reducing market growth opportunities in a sector that thrives on technological advancements and competitive pricing.

Market Trends of the Global His-Tag Antibody Market

The Global His-Tag Antibody market is witnessing a dynamic shift toward targeted affinity optimization, driven by advancements in protein engineering and high-throughput screening techniques. Manufacturers are focusing on creating antibodies with enhanced binding specificity, which mitigates non-specific interactions and enhances assay reliability. This need for improved reproducibility in laboratories has prompted vendors to offer customized tag variants and optimized buffer systems, facilitating consistent performance without the need for extensive method redevelopment. Consequently, the market is increasingly embracing next-generation antibody platforms that prioritize functional precision, marking a significant evolution from generic solutions to highly tailored products within the industry.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global His-Tag Antibody Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
• Polyclonal Antibodies

Global His-Tag Antibody Market Size by Label Type & CAGR (2026-2033)

• Market Overview
• Unconjugated
• HRP Conjugated
• Fluorescent Conjugated
• Others

Global His-Tag Antibody Market Size by Application & CAGR (2026-2033)

• Market Overview
• Western Blotting
• ELISA
• Immunoprecipitation
• Others

Global His-Tag Antibody Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Academic Institutes
• CROs

Global His-Tag Antibody Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors

Global His-Tag Antibody Market Size by Geography & CAGR (2026-2033)

• Market Overview
• North America
• Europe
• Asia-Pacific
• Rest of the World

Global His-Tag Antibody Market Size & CAGR (2026-2033)

• North America (Product Type, Label Type, Application, End User, Distribution Channel, Geography)
  • US
  • Canada
• Europe (Product Type, Label Type, Application, End User, Distribution Channel, Geography)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Label Type, Application, End User, Distribution Channel, Geography)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Label Type, Application, End User, Distribution Channel, Geography)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Label Type, Application, End User, Distribution Channel, Geography)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteintech Group, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santa Cruz Biotechnology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneTex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novus Biologicals LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abnova Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland Immunochemicals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boster Biological Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LSBio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invitrogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atlas Antibodies AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations